$49.16
0.65% yesterday
Nasdaq, Sep 27, 10:00 pm CET
ISIN
US46266A1097
Symbol
IRMD

iRadimed Corp Stock price

$49.16
+2.75 5.93% 1M
+5.79 13.35% 6M
+1.69 3.56% YTD
+5.68 13.07% 1Y
+16.93 52.52% 3Y
+29.01 143.94% 5Y
+42.48 635.96% 10Y
Nasdaq, Closing price Fri, Sep 27 2024
-0.32 0.65%
ISIN
US46266A1097
Symbol
IRMD
Sector

Key metrics

Market capitalization $626.90m
Enterprise Value $578.73m
P/E (TTM) P/E ratio 33.83
EV/FCF (TTM) EV/FCF 42.62
EV/Sales (TTM) EV/Sales 8.33
P/S ratio (TTM) P/S ratio 9.02
P/B ratio (TTM) P/B ratio 7.87
Dividend yield 0.00%
Last dividend (FY22) $0.96
Revenue growth (TTM) Revenue growth 16.05%
Revenue (TTM) Revenue $69.48m
EBIT (operating result TTM) EBIT $21.44m
Free Cash Flow (TTM) Free Cash Flow $13.58m
Cash position $48.54m
EPS (TTM) EPS $1.46
P/E forward 34.85
P/S forward 8.60
EV/Sales forward 7.94
Short interest 0.97%
Show more

Is iRadimed Corp a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,901 stocks worldwide.

iRadimed Corp Stock Analysis

Unlock Scores for Free

Analyst Opinions

2 Analysts have issued a iRadimed Corp forecast:

2x Buy
100%

Analyst Opinions

2 Analysts have issued a iRadimed Corp forecast:

Buy
100%

Financial data from iRadimed Corp

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
69 69
16% 16%
100%
- Direct Costs 16 16
11% 11%
23%
54 54
17% 17%
77%
- Selling and Administrative Expenses 26 26
4% 4%
37%
- Research and Development Expense 5.73 5.73
101% 101%
8%
22 22
23% 23%
32%
- Depreciation and Amortization 0.82 0.82
15% 15%
1%
EBIT (Operating Income) EBIT 21 21
24% 24%
31%
Net Profit 19 19
27% 27%
27%

In millions USD.

Don't miss a Thing! We will send you all news about iRadimed Corp directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

iRadimed Corp Stock News

Neutral
GlobeNewsWire
17 days ago
WINTER SPRINGS, Fla., Sept. 10, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (“Iradimed”) (NASDAQ: IRMD), a leading provider of innovative magnetic resonance imaging (MRI) compatible medical devices, announced today that the Company will be participating in the Lake Street 8 th  Annual Best Ideas Growth "Big 8" Conference.
Neutral
Seeking Alpha
about 2 months ago
IRADIMED CORPORATION (NASDAQ:IRMD ) Q2 2024 Results Conference Call August 1, 2024 12:00 PM ET Company Participants Roger Susi - President and Chief Executive Officer Matt Garner - Controller Conference Call Participants Frank Takkinen - Lake Street Capital Jason Wittes - ROTH Capital Partners Operator Welcome to the IRadimed Corporation Second Quarter of 2024 Financial Results Conference Call....
Neutral
GlobeNewsWire
about 2 months ago
WINTER SPRINGS, Fla., Aug. 01, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) announced today its financial results for the three and six months ended June 30, 2024. The Company is a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only known provider of a non-magnetic intravenous (“IV”) infusion pump system, and no...
More iRadimed Corp News

Company Profile

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging (MRI) compatible medical devices and accessories and services. It also provides non-magnetic Intravenous (IV) infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.

Head office United States
CEO Roger Susi
Employees 148
Founded 1992
Website www.iradimed.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today